Related references
Note: Only part of the references are listed.Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration
S. R. Heller et al.
DIABETOLOGIA (2007)
Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled study
A. J. Garber et al.
DIABETES OBESITY & METABOLISM (2007)
Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes
J. Rosenstock et al.
DIABETES OBESITY & METABOLISM (2007)
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial
M. A. Nauck et al.
DIABETES OBESITY & METABOLISM (2007)
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Steven E. Kahn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes
Pablo Aschner et al.
DIABETES CARE (2006)
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
Bernard Charbonnel et al.
DIABETES CARE (2006)
Hypoglycemia in type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis:: UKPDS73
Alex D. Wright et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2006)
The place of sulfonylureas in the therapy for type 2 diabetes mellitus
S Del Prato et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Insulin glargine or NPH combined with metformin in type 2 diabetes:: the LANMET study
H Yki-Järvinen et al.
DIABETOLOGIA (2006)
Resistance to insulin therapy among patients and providers - Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study
M Peyrot et al.
DIABETES CARE (2005)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes
RE Davis et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Health-related quality of life in the VA Feasibility Study on glycemic control and complications in Type 2 diabetes mellitus
S Pitale et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2005)
Improvement of glycemic control in subjects with poorly controlled type 2 diabetes - Comparison of two treatment algorithms using insulin glargine
M Davies et al.
DIABETES CARE (2005)
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea
DM Kendall et al.
DIABETES CARE (2005)
Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes
RA DeFronzo et al.
DIABETES CARE (2005)
Hypoglycemia in type 2 diabetes
S Banarer et al.
MEDICAL CLINICS OF NORTH AMERICA (2004)
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes
JB Buse et al.
DIABETES CARE (2004)
Hypoglycemia as a barrier to glycemic control
S Davis et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2004)
Hormonal counterregulation and consecutive glimepiride serum concentrations during severe hypoglycaemia associated with glimepiride therapy
A Holstein et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness
JN Henderson et al.
DIABETIC MEDICINE (2003)
Clinical characterisation of severe hypoglycaemia - a prospective population-based study
A Holstein et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2003)
Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance®) in type 2 diabetes
A Garber et al.
DIABETES OBESITY & METABOLISM (2003)
Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes - A population-based study of health service resource use
GP Leese et al.
DIABETES CARE (2003)
Acarbose in the treatment of elderly patients with type 2 diabetes
RG Josse et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2003)
Incidence and costs of severe hypoglycemia
A Holstein et al.
DIABETES CARE (2002)
Hypoglycemia-associated autonomic failure in advanced type 2 diabetes
SA Segel et al.
DIABETES (2002)
Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide
A Holstein et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2001)
Hypoglycemia in patients with type 2 diabetes mellitus
CD Miller et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)
KT Khaw et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
What do patients with diabetes know about their tablets?
DL Browne et al.
DIABETIC MEDICINE (2000)
Share Paper
